PRLD compared with TRAW: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

TRAWTraws Pharma, Inc.

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

TRAWTraws Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only TRAW 3

—Temple Universityunlistedsupplier

—Viriomunlistedsupplier

—HanX Biopharmaceuticalsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PRLDPrelude Therapeutics Inc

3.84· pre 3.84· delayed

Mkt cap$306.4MRevenue$6MQ2 FY26Revenue—

TRAWTraws Pharma, Inc.

0.30· pre 0.30· delayed

Pre-marketNov 2 '26delayed

Mkt cap$4.5MRevenue$3MQ2 FY25Revenue$3MFY24

Compare

Pre-marketNov 2 '26delayed

PRLDPrelude Therapeutics Inc

TRAWTraws Pharma, Inc.

3.84pre 3.84delayed

Price

0.30pre 0.30delayed

$306.4M

Mkt cap

$4.5M

Q2 FY26$6M

Revenue

$3MQ2 FY25

—

Revenue

$3MFY24

PRLD3.84vsTRAW0.30Pre-marketNov 2 '26delayed